Literature DB >> 9793482

Research on heterocyclic compounds, Part 40. 2-Phenylimidazo[1,2-a]pyridine-3-carboxylic acid derivatives: synthesis and antiinflammatory activity.

A Di Chiacchio1, M G Rimoli, L Avallone, F Arena, E Abignente, W Filippelli, A Filippelli, G Falcone.   

Abstract

A series of 2-phenylimidazo[1,2-a]pyridine-3-carboxylic esters, acids, and amides were synthesized and pharmacologically tested in order to evaluate their antiinflammatory and analgesic activity and their ulcerogenic action on the gastro-intestinal tract. The most active member of this series of compounds was found to be 6-methyl-2-phenylimidazo[1,2-a]pyridine-3-carboxylic acid (5c).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9793482     DOI: 10.1002/(sici)1521-4184(19989)331:9<273::aid-ardp273>3.0.co;2-r

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  4 in total

1.  One-pot synthesis of 2-phenylimidazo[1,2-α]pyridines from acetophenone, [Bmim]Br(3) and 2-aminopyridine under solvent-free conditions.

Authors:  Zhang-Gao Le; Zong-Bo Xie; Jian-Ping Xu
Journal:  Molecules       Date:  2012-11-09       Impact factor: 4.411

2.  De novo design and synthesis of dipyridopurinone derivatives as visible-light photocatalysts in productive guanylation reactions.

Authors:  Yameng Wan; Hao Wu; Nana Ma; Jie Zhao; Zhiguo Zhang; Wenjing Gao; Guisheng Zhang
Journal:  Chem Sci       Date:  2021-11-13       Impact factor: 9.825

3.  An efficient synthesis of new imidazo[1,2-a]pyridine-6-carbohydrazide and pyrido[1,2-a]pyrimidine-7-carbohydrazide derivatives via a five-component cascade reaction.

Authors:  Hajar Hosseini; Mohammad Bayat
Journal:  RSC Adv       Date:  2019-03-05       Impact factor: 4.036

4.  Synthesis of 5-amino-N'-(9H-fluoren-9-ylidene)-8-nitro-7-aryl-1,2,3,7-tetrahydroimidazo[1,2-a]pyridine-6-carbohydrazide derivatives based on heterocyclic ketene aminals.

Authors:  Hajar Hosseini; Mohammad Bayat
Journal:  RSC Adv       Date:  2018-12-11       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.